NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NICHD E-155-1999-0-IE-24 17-Alpha-Substituted 11-Beta-4-Substituted-Aryl and 21-Substituted 19 Norpregnadienedione as New Antiprogestational IE EP 01918812.7 Abandoned
NICHD E-155-1999-0-GB-16 17-Alpha-Substituted 11-Beta-4-Substituted-Aryl and 21-Substituted 19 Norpregnadienedione as New Antiprogestational GB EP 01918812.7 Abandoned
NICHD E-155-1999-0-TR-22 17-Alpha-Substituted 11-Beta-4-Substituted-Aryl and 21-Substituted 19 Norpregnadienedione as New Antiprogestational TR EP 01918812.7 Abandoned
NICHD E-155-1999-0-CH-10 17-Alpha-Substituted 11-Beta-4-Substituted-Aryl and 21-Substituted 19 Norpregnadienedione as New Antiprogestational CH EP 01918812.7 Abandoned
NICHD E-155-1999-0-EP-05 17-Alpha-Substituted 11-Beta-Substituted-4-Aryl and 21-Substituted 19-Norpregnadienedione as New Antiprogestational Agents EP National Stage 01918812.7 Abandoned
NICHD E-155-1999-0-DE-12 17-Alpha-Substituted 11-Beta-4-Substituted-Aryl and 21-Substituted 19 Norpregnadienedione as New Antiprogestational DE EP 01918812.7 Abandoned
NICHD E-155-1999-0-FR-15 17-Alpha-Substituted 11-Beta-4-Substituted-Aryl and 21-Substituted 19 Norpregnadienedione as New Antiprogestational FR EP 01918812.7 Abandoned
NICHD E-155-1999-0-NL-19 17-Alpha-Substituted 11-Beta-4-Substituted-Aryl and 21-Substituted 19 Norpregnadienedione as New Antiprogestational NL EP 01918812.7 Abandoned
NICHD E-155-1999-0-LU-26 17-Alpha-Substituted 11-Beta-4-Substituted-Aryl and 21-Substituted 19 Norpregnadienedione as New Antiprogestational LU EP 01918812.7 Abandoned
NICHD E-155-1999-0-MC-18 17-Alpha-Substituted 11-Beta-4-Substituted-Aryl and 21-Substituted 19 Norpregnadienedione as New Antiprogestational MC EP 01918812.7 Abandoned
NIMH E-059-1998-0-US-02 Use of Immunotoxins to Induce Immune Tolerance to Pancreatic Islet Transplantation US CON 09/810,999 7288254 Expired PDF
NICHD E-155-1999-0-AU-03 Structural Modification of 19-Norpregnadienedione I: 17-a-Alpha-Substituted-11-Beta-4-Aryl and 21-Substituted 19-Norpregnadienedione as New Antiprogestational Agents AU National Stage 2001245849 Abandoned
NIDDK E-163-1991-2-US-02 A Method for Reducing the Immunogenicity of Antibody Variable Domains US CON 09/810,502 6797492 Expired PDF
NINDS E-235-1998-0-US-03 CELL EXPANSION SYSTEM FOR USE IN NEURAL TRANSPLANTATION US National Stage 09/744,384 6787356 Expired PDF
NICHD E-155-1999-0-PCT-02 Structural Modification of19-Norprogesterone I: 17-a-Substituted,11-alpha-Substituted-4Aryl and 21-Substituted 19-Norpregnadienedione As New Antiprogestational Agents PCT PCT PCT/US01/08681 Expired
NICHD E-155-1999-0-EP-27 17-Alpha-Substituted 11-Beta-4-Substituted-Aryl and 21-Substituted 19 Norpregnadienedione as Antiprogestational Agents EP DIV 08009259.6 Abandoned
NICHD E-155-1999-0-JP-30 STRUCTURAL MODIFICATION OF 19-NORPROGESTERONE I: 17-a-SUBSTITUTED-11-B-SUBSTITUTED-4-ARYL AND 21-SUBSTITUTED 19-NORPREGNADIENEDIONE AS NEW ANTIPROGESTATIONAL AGENTS JP DIV 2011-244014 Abandoned
NEI E-241-1999-0-US-01 Ocular Therapeutic Agent Delivery Devices And Methods For Making And Using Such Devices US ORD 09/808,149 6713081 Expired PDF
NCI E-197-2000-0-PCT-02 Transfer Microdissection PCT PCT PCT/US2001/008095 Expired
NCI E-197-2000-0-EP-05 Transfer Microdissection EP National Stage 01918647.7 Abandoned
NCI E-128-2000-0-US-02 Methods and Compositions For Co-Stimulation Of Immunological Responses To Peptide Antigens US ORD 09/810,310 Abandoned
NCI E-197-2000-0-CA-04 Transfer Microdissection CA National Stage 2415864 Abandoned
NINDS E-012-2000-0-US-01 Postsynaptic Response By Increasing Intracellular Calcium US 60/275,463 Abandoned
NCI E-323-2000-0-US-01 Activated Dual Specificity T Lymphocytes and Their Methods of Use US ORD 09/803,578 7723111 Abandoned PDF
NCI E-321-2000-0-US-01 Antisense Oligonucleotides Targeting Folate Receptor Alpha, And the Use Thereof US 60/274,249 Abandoned
NHGRI E-140-1999-1-US-01 Novel Methods and Reagents for the Treatment of Ostheoarthritis US CIP 09/802,207 Expired
NIAID E-115-2001-2-US-01 MVA Expressing Modified HIV Envelope, Gag And Pol Genes US 60/274,434 Abandoned
NCI E-200-1998-0-US-02 Fitness Assay and Associated Methods US National Stage 09/720,276 7470506 Expired PDF
NCI E-035-1998-0-US-06 Pteridine Nucleotide Analogs US National Stage 09/786,666 6716971 Abandoned PDF
NIAID E-205-1998-0-US-03 Inhibitors of Amyloid Formation US National Stage 09/762,725 6632808 Abandoned PDF
NCI E-311-2000-0-US-01 Thymidylate Synthase Peptides That Bind To Thymidylate Synthase Messenger RNA US 60/274,107 Abandoned
NIAID E-115-2001-1-US-01 MVA Expressing Modified HIV Envelope, Gag And Pol Genes US 60/274,626 Abandoned
NCI E-289-1999-0-CA-04 1,8-Naphthalimide Imidazo[4,5,1-de] acridones with Anti-Tumor Activity CA National Stage 2402446 Abandoned
NCI E-289-1999-0-AU-03 1,8-Naphthalimide Imidazo[4,5,1-de] acridones with Anti-Tumor Activity AU National Stage 2001240054 Abandoned
NCI E-289-1999-0-EP-06 1,8-Naphthalimide Imidazo[4,5,1-de] Acridones with Anti-Tumor Activity EP National Stage 01914696.8 Abandoned
NCI E-289-1999-0-DE-09 1,8-Naphthalimide Imidazo[4,5,1-de] Acridones with Anti-Tumor Activity DE EP 01914696.8 Abandoned
NCI E-289-1999-0-FR-08 1,8-Naphthalimide Imidazo[4,5,1-de] Acridones with Anti-Tumor Activity FR EP 01914696.8 Abandoned
NCI E-289-1999-0-CH-10 1,8-Naphthalimide Imidazo[4,5,1-de] Acridones with Anti-Tumor Activity CH EP 01914696.8 Abandoned
NCI E-289-1999-0-GB-11 1,8-Naphthalimide Imidazo[4,5,1-de] Acridones with Anti-Tumor Activity GB EP 01914696.8 Abandoned
NIDDK E-006-1998-2-US-01 Methods And Compositions For Reducing Ischemic Injury Of The Heart By Aministering Adenosine Receptor Agonists And Antagonists US CIP 09/800,274 6586413 Expired PDF
NCI E-289-1999-0-PCT-02 1,8-Naphthalimide Imidazo[4,5,1-de] Acridones With Anti-Tumor Activity PCT PCT PCT/US01/07087 Expired
NCI E-289-1999-0-JP-05 1,8-Naphthalimide Imidazo[4,5,1-de] acridones with Anti-Tumor Activity JP National Stage 2001-565361 Abandoned
NCI E-313-2001-0-US-01 Nucleic Acids of The Human ABCC12 Gene, Vector Containing Such Nucleic Acids And Uses Thereof US 60/272,759 Abandoned
NCI E-312-2001-0-US-01 Nucleic Acids of The Human ABCC11 Gene, Vectors Containing Such Nucleic Acids And Uses Thereof US 60/272,757 Abandoned
NIAID E-232-2004-2-CA-04 DNA Expression Vectors and Methods of Use CA National Stage 2401974 Expired
NIAID E-232-2004-2-AU-03 DNA Expression Vectors and Methods of Use AU National Stage 2002211948 Abandoned
NIAID E-232-2004-2-CN-07 DNA Expression Vectors and Methods of Use CN National Stage 01818162.7 Expired
NIAID E-232-2004-2-PCT-02 DNA expression vectors and methods of use PCT PCT PCT/US2001/006795 Expired
NIAID E-232-2004-2-US-01 DNA Expression Vectors and Methods of Use US CIP 09/798,675 Abandoned
NIAID E-232-2004-2-EP-05 DNA Expression Vectors and Methods of Use EP National Stage 01981921.8 Expired